Kerem Ben-Meir
Overview
Explore the profile of Kerem Ben-Meir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
85
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reuven O, Mikula Jr I, Ashkenazi-Preiser H, Twaik N, Ben-Meir K, Meirow Y, et al.
Curr Protoc
. 2024 Dec;
4(12):e70082.
PMID: 39688138
No abstract available.
2.
Berckmans Y, Ene H, Ben-Meir K, Martinez-Conde A, Wouters R, Van den Ende B, et al.
Front Oncol
. 2024 Jul;
14:1402851.
PMID: 38993641
Background: Ovarian cancer is the leading cause of mortality among gynecological malignancies. Carboplatin and poly (ADP-ribose) polymerase inhibitors (PARPi) are often implemented in the treatment of ovarian cancer. Homologous recombination...
3.
Ashkenazi-Preiser H, Reuven O, Uzan-Yulzari A, Komisarov S, Cirkin R, Turjeman S, et al.
Cancer Res Commun
. 2024 Mar;
4(4):1063-1081.
PMID: 38506672
Significance: MDSCs-dysbiotic bacteria interactions in the intestine play a crucial role in intensifying immunosuppression within the CAC microenvironment, ultimately facilitating tumor growth, highlighting potential therapeutic targets for improving the treatment...
4.
Reuven O, Mikula Jr I, Ashkenazi-Preiser H, Twaik N, Ben-Meir K, Meirow Y, et al.
Curr Protoc
. 2022 Oct;
2(10):e557.
PMID: 36282094
Myeloid-derived suppressor cells (MDSCs) are heterogenous populations of immature myeloid cells that can be divided into two main subpopulations, polymorphonuclear (PMN) MDSCs and monocytic (M) MDSCs. These cells accumulate during...
5.
Ben-Meir K, Twaik N, Meirow Y, Baniyash M
Curr Protoc
. 2022 Oct;
2(10):e558.
PMID: 36239438
Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population of immature myeloid cells known to play a role in perpetuating a wide range of pathologies, such as chronic infections, autoimmune diseases,...
6.
Reuven O, Mikula Jr I, Ashkenazi-Preiser H, Twaik N, Ben-Meir K, Meirow Y, et al.
Curr Protoc
. 2022 Oct;
2(10):e561.
PMID: 36214619
Myeloid-derived suppressor cells (MDSCs) are heterogenous populations of immature myeloid cells that can be divided into two main subpopulations, polymorphonuclear (PMN) MDSCs and monocytic (M) MDSCs. These cells accumulate during...
7.
Meirow Y, Jovanovic M, Zur Y, Habib J, Colombo D, Twaik N, et al.
Bone Res
. 2022 Apr;
10(1):36.
PMID: 35396510
Elevated osteoclast (OC) activity is a major contributor to inflammatory bone loss (IBL) during chronic inflammatory diseases. However, the specific OC precursors (OCPs) responding to inflammatory cues and the underlying...
8.
Maimon A, Levi-Yahid V, Ben-Meir K, Halpern A, Talmi Z, Priya S, et al.
J Clin Invest
. 2021 Apr;
131(10).
PMID: 33848267
Stimulation of TAM (TYRO3, AXL, and MERTK) receptor tyrosine kinases promotes tumor progression through numerous cellular mechanisms. TAM cognate ligands GAS6 and PROS1 (for TYRO3 and MERTK) are secreted by...
9.
Ben-Meir K, Twaik N, Baniyash M
Curr Opin Immunol
. 2018 Apr;
51:154-161.
PMID: 29614426
Myeloid derived suppressor cells (MDSCs) are immature myeloid cells characterized by diverse phenotypes and functions. They impair effector functions of immune cells and promote tumor growth, angiogenesis, and tissue damage....